ACRO Biomedical Co., Ltd. (TPEX:6748)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
118.50
-9.00 (-7.06%)
Jun 18, 2026, 2:59 PM CST
Market Cap8.44B +268.6%
Revenue (ttm)38.26M -13.5%
Net Income-82.66M
EPS-1.35
Shares Out 71.22M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,178,110
Open124.50
Previous Close127.50
Day's Range114.50 - 128.50
52-Week Range33.85 - 137.00
Beta0.37
Analystsn/a
Price Targetn/a
Earnings DateAug 11, 2026

About ACRO Biomedical

ACRO Biomedical Co., Ltd. develops medical-grade regenerative biomaterials. The company offers products in the areas of wound care, orthopedics, dentistry, ophthalmology, cosmetic micro plastic surgery, beauty and eye care, and tissue engineering and regenerative medicines. The company was founded in 2014 and is based in Kaohsiung, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6748
Full Company Profile

Financial Performance

In 2025, ACRO Biomedical's revenue was 38.26 million, a decrease of -13.51% compared to the previous year's 44.23 million. Losses were -82.66 million, 33.1% more than in 2024.

Financial Statements